361 related articles for article (PubMed ID: 27605722)
21. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease.
Menon V; Greene T; Wang X; Pereira AA; Marcovina SM; Beck GJ; Kusek JW; Collins AJ; Levey AS; Sarnak MJ
Kidney Int; 2005 Aug; 68(2):766-72. PubMed ID: 16014054
[TBL] [Abstract][Full Text] [Related]
22. Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis.
Kochi M; Kohagura K; Shiohira Y; Iseki K; Ohya Y
J Cardiol; 2018 Mar; 71(3):277-283. PubMed ID: 28969969
[TBL] [Abstract][Full Text] [Related]
23. Does chronic kidney disease modify the association between body mass index and cardiovascular disease risk factors.
Bansal N; Vittinghoff E; Plantinga L; Hsu CY
J Nephrol; 2012; 25(3):317-24. PubMed ID: 21725923
[TBL] [Abstract][Full Text] [Related]
24. Effects of Salacia oblonga on cardiovascular risk factors in chronic kidney disease patients: a prospective study.
Singh RG; Rathore SS; Wani IA; ; Agrawal A; Dubey GP
Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):61-6. PubMed ID: 25579717
[TBL] [Abstract][Full Text] [Related]
25. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5.
Chiu H; Wu PY; Huang JC; Tu HP; Lin MY; Chen SC; Chang JM
Sci Rep; 2020 Jul; 10(1):12749. PubMed ID: 32728174
[TBL] [Abstract][Full Text] [Related]
26. Longitudinal and cross-sectional effects of C-reactive protein, equilibrated normalized protein catabolic rate, and serum bicarbonate on creatinine and albumin levels in dialysis patients.
Kaysen GA; Greene T; Daugirdas JT; Kimmel PL; Schulman GW; Toto RD; Levin NW; Yan G;
Am J Kidney Dis; 2003 Dec; 42(6):1200-11. PubMed ID: 14655192
[TBL] [Abstract][Full Text] [Related]
27. Dietary inflammatory index: a potent association with cardiovascular risk factors among patients candidate for coronary artery bypass grafting (CABG) surgery.
Farhangi MA; Najafi M
Nutr J; 2018 Feb; 17(1):20. PubMed ID: 29439738
[TBL] [Abstract][Full Text] [Related]
28. Relationship between liver function tests & cardiovascular risk factors in stage 3-5 pre-dialysis chronic kidney disease.
Selen T; Akoglu H; Agbaht K
Indian J Med Res; 2022 Mar; 155(3&4):397-402. PubMed ID: 35975350
[TBL] [Abstract][Full Text] [Related]
29. Effects of atorvastatin on renal function in patients with dyslipidemia and chronic kidney disease: assessment of clinical usefulness in CKD patients with atorvastatin (ASUCA) trial.
Kimura G; Kasahara M; Ueshima K; Tanaka S; Yasuno S; Fujimoto A; Sato T; Imamoto M; Kosugi S; Nakao K
Clin Exp Nephrol; 2017 Jun; 21(3):417-424. PubMed ID: 27392909
[TBL] [Abstract][Full Text] [Related]
30. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease.
Menon V; Wang X; Greene T; Beck GJ; Kusek JW; Marcovina SM; Levey AS; Sarnak MJ
Am J Kidney Dis; 2003 Jul; 42(1):44-52. PubMed ID: 12830455
[TBL] [Abstract][Full Text] [Related]
31. Low HDL cholesterol as a predictor of chronic kidney disease progression: a cross-classification approach and matched cohort analysis.
Kawachi K; Kataoka H; Manabe S; Mochizuki T; Nitta K
Heart Vessels; 2019 Sep; 34(9):1440-1455. PubMed ID: 30874893
[TBL] [Abstract][Full Text] [Related]
32. Effects of lipoprotein-associated phospholipase A2 on arginase/nitric oxide pathway in hemodialysis patients.
Tektaş AK; Uslu S; Yalçin AU; Sahin G; Temiz G; Kara M; Temel HE; Demirkan ES; Colak E; Colak O
Ren Fail; 2012; 34(6):738-43. PubMed ID: 22583316
[TBL] [Abstract][Full Text] [Related]
33. Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis.
Jing Z; Wei-Jie Y
Clin Nutr; 2016 Feb; 35(1):117-124. PubMed ID: 25882339
[TBL] [Abstract][Full Text] [Related]
34. Plasma C-reactive protein levels and their relationship to anthropometric and lipid characteristics among children.
Wu DM; Chu NF; Shen MH; Chang JB
J Clin Epidemiol; 2003 Jan; 56(1):94-100. PubMed ID: 12589876
[TBL] [Abstract][Full Text] [Related]
35. Assessment of iron deficiency anaemia and its risk factors among adults with chronic kidney disease in a tertiary hospital in Nigeria.
Raji YR; Ajayi SO; Akingbola TS; Adebiyi OA; Adedapo KS; Salako BL
Niger Postgrad Med J; 2018; 25(4):197-203. PubMed ID: 30588939
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and Pattern of Chronic Kidney Disease and its Associated Risk Factors in a Rural Community in South Western Nigeria.
Oyebisi OO; Okunola OO; Jaiyesimi AE; Arogundade FA; Adelaja MA; Erohibe CE; Sanusi AA; Akinsola A
West Afr J Med; 2018; 35(2):109-116. PubMed ID: 30027996
[TBL] [Abstract][Full Text] [Related]
37. Correlation of carotid intimal-medial thickness with estimated glomerular filtration rate and cardiovascular risk factors in chronic kidney disease.
Chhajed N; Subhash Chandra BJ; Shetty MS; Shetty C
Saudi J Kidney Dis Transpl; 2014 May; 25(3):572-6. PubMed ID: 24821154
[TBL] [Abstract][Full Text] [Related]
38. Relationships among changes in C-reactive protein and cardiovascular disease risk factors with lifestyle interventions.
Young D; Camhi S; Wu T; Hagberg J; Stefanick M
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):857-63. PubMed ID: 22831953
[TBL] [Abstract][Full Text] [Related]
39. C-reactive protein as a predictor of cardiovascular events in elderly patients with chronic kidney disease.
Jalal D; Chonchol M; Etgen T; Sander D
J Nephrol; 2012; 25(5):719-25. PubMed ID: 22038335
[TBL] [Abstract][Full Text] [Related]
40. High-sensitivity C-reactive protein and total antioxidant status in patients with essential arterial hypertension and dyslipidemia.
Kuklinska AM; Mroczko B; Musial WJ; Sawicki R; Kozieradzka A; Waszkiewicz E; Szmitkowski M
Adv Med Sci; 2009; 54(2):225-32. PubMed ID: 20053618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
